United States · Venture startup
7 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$194Mraised across 7 rounds since 2005, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
OrbiMed
Gimv
Roche Venture Fund
Aisling Capital
Forward Ventures
Radius Ventures
Apposite CapitalReported by phx.corporate-ir.netSEC filing: $22M sold, first sale Oct 2012
OrbiMedGimvRoche Venture Fund
Horizon Technology FinanceForward VenturesRadius VenturesApposite Capital
QuintilesReported by phx.corporate-ir.netSEC filing: $22M sold, first sale May 2011
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Sept 2010
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale Mar 2010
No investor was named in the report.
From a historical funding recordSEC filing: $6.4M sold, first sale Jun 2009
OrbiMedGimvRoche Venture FundHorizon Technology FinanceForward VenturesRadius Ventures
NovaQuestApposite CapitalFrom a historical funding record
GimvRoche Venture FundForward VenturesFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
GimvRoche Venture FundForward VenturesOrbiMedMedImmune VenturesRadius VenturesApposite CapitalAvalon VenturesGrowthWorksHorizon Technology FinanceFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Ambit Biosciences's investors include Gimv, Roche Venture Fund, Forward Ventures, OrbiMed and MedImmune Ventures, and 11 more on record.
Ambit Biosciences has raised $194M across 7 rounds since 2005.
Ambit Biosciences's most recent round was a Venture of $50M in Nov 2012.
Its most recent round, $50M in Nov 2012, is also its largest on record.
Ambit Biosciences's first round on record, in May 2005, was backed by Avalon Ventures, Gimv and Roche Venture Fund and 4 others.
Ambit Biosciences's latest named round is a Venture, in Nov 2012.
Ambit Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·